Related Experiment Video
Updated: Feb 14, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Silymarin prevents diabetes-induced hyperpermeability in human retinal endothelial cells
Marta García-Ramírez1, Mireia Turch2, Olga Simó-Servat1
1Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute. Universitat Autònoma de Barcelona, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain.
Introduction:
Vascular endothelial growth factor (VEGF) plays an essential role in development of diabetic macular edema (DME). While there is evidence suggesting that silymarin, a flavonoid extracted from Silybum marianum, could be useful for prevention and treatment of diabetic nephropathy, no studies have been conducted in diabetic retinopathy (DR). The aim of this study was to assess the effect of silymarin on disruption of inner blood retinal barrier (BRB), the primary cause of DME.
Materials And Methods:
Human retinal endothelial cells (HRECs) were cultured under standard (5.5mM D-glucose) and diabetogenic conditions (25mM D-glucose and 25mM D-glucose + recombinant vascular endothelial growth factor [rVEGF, 25mg/mL]). To assess cell viability, three concentrations of silymarin were tested (2, 4 and 10μg/mL). The effect of silymarin on HREC disruption was determined using a dextran (70kD) permeability asssay.
Results:
No differences were found in the viability of HRECs treated with 2 or 4μg/mL of silymarin as compared to untreated cells, but viability significantly decreased after using 10μg/mL. The concentration of 4 μg/mL was therefore selected. Silymarin (4μg/mL) caused a significant decrease in VEGF-induced permeability in both media with 5.5nM (422±58 vs. 600±72 ng/mL/cm2; p<0.03) and 25nM of D-glucose (354 ± 28 vs. 567 ± 102 ng/mL/cm2; p<0.04).
Discussion:
Our results show that silymarin is effective for preventing hyperpermeability induced by diabetic conditions in HRECs. Further studies are needed to assess whether silymarin could be useful to treat DME.
Insights
Silymarin effectively prevents increased blood-retinal barrier permeability in human retinal endothelial cells under diabetic conditions. Further research is needed to explore its potential for treating diabetic macular edema (DME).
Area of Science:
- Ophthalmology
- Cell Biology
- Pharmacology
Background:
- Diabetic macular edema (DME) is linked to vascular endothelial growth factor (VEGF).
- Silymarin, a flavonoid from Silybum marianum, shows potential for diabetic nephropathy but lacks study in diabetic retinopathy (DR).
- This study investigates silymarin's effect on the inner blood-retinal barrier (BRB) disruption in DME.
Purpose of the Study:
- To assess silymarin's impact on the inner blood-retinal barrier (BRB) in human retinal endothelial cells (HRECs) under diabetic conditions.
- To determine the efficacy of silymarin in preventing VEGF-induced hyperpermeability in HRECs.
Main Methods:
- HRECs were cultured in standard (5.5mM D-glucose) and diabetic (25mM D-glucose) conditions, with or without recombinant VEGF.
- Cell viability was tested with silymarin concentrations of 2, 4, and 10μg/mL.
- Dextran permeability assay measured HREC disruption, with 4μg/mL silymarin selected based on viability results.
Main Results:
- Silymarin at 4μg/mL did not affect HREC viability.
- Silymarin significantly reduced VEGF-induced permeability in both standard and diabetic conditions.
- The reduction in permeability was observed in both 5.5nM and 25nM D-glucose media.
Conclusions:
- Silymarin demonstrates effectiveness in preventing diabetic-induced hyperpermeability in HRECs.
- These findings suggest silymarin's potential therapeutic value for DME.
- Further clinical studies are warranted to confirm silymarin's efficacy in treating DME.
Related Concept Videos
Induced Pluripotent Stem Cells
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

